Louisville Bioscience Licenses Dx Tech from U of Louisville’s Brown Cancer Center
Louisville Bioscience has exclusively licensed a screening and diagnostic platform based on differential scanning calorimetry from the University of Louisville James Graham Brown Cancer Center, the school said last week.
The technology can be used to analyze bodily fluids, especially blood plasma, for the purposes of disease screening. LBI hopes to develop the technology further into early-stage diagnostic tests for a variety of diseases.
In preliminary testing, blood plasma from individuals with rheumatoid arthritis, Lyme disease, and lupus produced patterns that differed significantly from those of healthy individuals.
Differential scanning calorimetry creates a visual map of how blood proteins behave when heated, providing clues to specific diseases, Louisville said. The technique was developed by U of L scientists Jonathan Chaires, Nichola Garbett, and Bennett Jenson.
Financial terms of the licensing agreement were not disclosed.